Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorized sale of an esketamine nasal spray for serious depression – five psychiatrists who used the therapy on their ...

Since October 2020 – when the Health Sciences Authority (HSA) first authorised sale of an esketamine nasal spray for serious depression – five psychiatrists who used the therapy on their ...

We are a leading provider of Transcranial Magnetic Stimulation (TMS) and esketamine nasal spray, both highly effective, FDA-approved depression treatments. With locations throughout California ...

Esketamine, branded as Spravato, is a nasal spray that works on different neurotransmitter systems in the brain than most other antidepressants. Arguably called “one of the most important ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster for Janssen ...

"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions of people affected by TRD," he added. Analysts at ...